Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.57ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.57NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FU.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FU.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.57ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.57NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used